NEJM.org

nejm.org

18 October 2026 12:17

Monoclonal antibodies targeting the interleukin-23 pathway, given intravenously or subcutaneously, are effective in inflammatory bowel disease. Research findings from the ANTHEM-UC trial are summarized in a new Quick Take video. https://nej.md/4s4CROE

bioRxiv Immunology

biorxiv-immuno.bsky.social

18 October 2026 12:16

Dual blockade of IL-18 and IL-4Rα by a bispecific antibody for improved treatment of atopic dermatitis https://www.biorxiv.org/content/10.64898/2026.10.11.758381v1

DrDrew

drgoatfarmer.bsky.social

10 October 2026 18:44

GC has very different meanings across specialties. 😂😂😂

Betty C. Jung

bettycjung.bsky.social

05 October 2026 18:25

Thank you so much for sharing the results of this research! I suppose, it's buyer beware! 40% placebo effect really says a lot about how people's expectations can affect how they view the effectiveness of a treatment. There's not enough hours in a day to keep up with new research! 😮‍💨

Rheum Cat

rheumcat.bsky.social

02 October 2026 14:45

YES it's like Christmas presents for me - the day the #ACR26 abstracts are released!! Please mute this hashtag because I will be posting hundreds of tagged posts about this meeting next month